Acadia Healthcare (ACHC) Tops Q2 EPS by 4c; offers guidance

Acadia Healthcare (NASDAQ: ACHC) reported Q2 EPS of $0.91, $0.04 better than the analyst estimate of $0.87. Revenue for the quarter came in at $796 million versus the consensus estimate of $784.38 million.

GUIDANCE:

Acadia Healthcare sees FY2024 EPS of $3.45-$3.65, versus the consensus of $3.49. Acadia Healthcare sees FY2024 revenue of $3.18-3.225 billion, versus the consensus of $3.2 billion.

For earnings history and earnings-related data on Acadia Healthcare (ACHC) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Isoplus selects Navan to manage global travel and expense program
• Morgan Stanley Upgrades QIAGEN NV (QIA:GR) (QGEN) to Overweight